Cargando…
Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma
To determine the suitability of serum endocan (ESM-1) levels for diagnosing and monitoring renal cell carcinoma (RCC), we measure serum ESM-1 levels in 56 RCC patients who had undergone radical or partial nephrectomies and 56 age- and sex-matched healthy kidney donors. Measurements were made before...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787497/ https://www.ncbi.nlm.nih.gov/pubmed/29416643 http://dx.doi.org/10.18632/oncotarget.23087 |